Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epcoritamab in Combination With R-CHOP Debulking in Newly Diagnosed Patients With Aggressive Non-Hodgkin Lymphoma (DLBCL)

NCT07588698 is registered in ClinicalTrials.gov with Carrie Ho, MD as lead sponsor.

NCT NCT07588698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07588698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epcoritamab in Combination With R-CHOP Debulking in Newly Diagnosed Patients With Aggressive Non-Hodgkin Lymphoma (DLBCL)
Lead sponsor
Carrie Ho, MD
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 15, 2026
Completion date
August 31, 2029
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma (dlbcl), lymphoma non-hodgkin, non-hodgkin's b-cell lymphoma